Last reviewed · How we verify
SFP Control
At a glance
| Generic name | SFP Control |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD (NA)
- A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia (PHASE2)
- Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program (NA)
- Evaluation of Thiwáhe Gluwáš'Akapi Substance Use Prevention Program (NA)
- Strengthening Families Program Online (NA)
- N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders (PHASE2, PHASE3)
- Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy (PHASE2)
- Adolescent Family-Based Alcohol Prevention (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SFP Control CI brief — competitive landscape report
- SFP Control updates RSS · CI watch RSS
- Bayer portfolio CI